Your cart is empty
Browse CatalogLarnaLabs operates with a commitment to legal, ethical, and regulatory compliance at every level of our business. We understand that research peptides exist within a complex and evolving regulatory landscape, and we take our responsibilities as a supplier to the research community seriously.
This page outlines our compliance framework, how we support our customers in meeting their obligations, and important information about the regulatory status of research peptides in key jurisdictions.
Every product sold by LarnaLabs is classified and sold exclusively as a research compound for in vitro laboratory use. This classification is not a formality — it reflects the fundamental nature of our products and defines the terms under which they may legally be purchased, imported, and used.
Research peptides are distinct from pharmaceutical drugs, food supplements, cosmetics, or veterinary medicines. They have not undergone the clinical trials, safety evaluations, or regulatory review processes required for approval as medicinal products. Accordingly, they are not approved for use in or on any human being or animal, and they may not be sold, marketed, or represented as having therapeutic, prophylactic, or diagnostic properties.
All purchasers of LarnaLabs products are required to acknowledge, at the time of purchase, that:
We implement the following measures to maintain compliance standards across our operations:
The import and export of research peptides is subject to national and international regulations that vary significantly by jurisdiction. LarnaLabs takes reasonable steps to comply with applicable export control laws and to restrict sales to jurisdictions where importation is permitted for research purposes.
Purchasers are solely responsible for verifying that:
LarnaLabs is not responsible for shipments delayed, seized, or destroyed by customs authorities. We will provide commercially reasonable documentation to support legitimate customs clearance, but we cannot guarantee clearance in any jurisdiction.
We provide standard commercial documentation with all international shipments, including:
If your institution or customs authority requires additional documentation (such as a Material Safety Data Sheet, a letter confirming research use, or additional chemical characterization data), please contact [email protected] at the time of ordering and we will do our best to accommodate your requirements.
The following uses of LarnaLabs products are strictly prohibited:
LarnaLabs reserves the right to refuse or cancel any order where there is reasonable suspicion that products will be used in violation of these prohibitions. Customers who violate these terms will be permanently banned from purchasing.
Purchasing research peptides from LarnaLabs entails a set of responsibilities that rest entirely with the purchaser. By completing a purchase, the researcher acknowledges that:
Regulatory frameworks for research peptides differ significantly between countries. The following is a general overview and does not constitute legal advice. Purchasers should consult local legal counsel or their institution’s regulatory affairs team for jurisdiction-specific guidance.
In the United States, research peptides that are not approved drugs may be legally purchased and possessed for bona fide research purposes. They may not be sold for human consumption or marketed with therapeutic claims. The FDA does not approve research-only compounds for human use. Researchers must ensure compliance with institutional review board (IRB) requirements and DEA regulations where applicable to their research. Some peptide classes may be subject to scheduling under the Controlled Substances Act or analogues act provisions — researchers are responsible for verifying the regulatory status of specific compounds.
Within the EU, research chemicals are subject to national regulations of member states in addition to EU-wide frameworks including REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) and applicable customs regulations. Research institutions must ensure compliance with local laws governing acquisition, storage, and use of research chemicals. Some compounds may require notification or registration under national chemicals legislation.
Following Brexit, the UK operates its own regulatory framework under the UK REACH regulation and the Medicines and Healthcare products Regulatory Agency (MHRA). Research compounds may be imported for legitimate scientific research purposes, subject to applicable customs controls. Researchers should verify the regulatory status of specific compounds under the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016 where relevant.
In Australia, importation of research chemicals may require a permit from the Office of Drug Control (ODC) or Therapeutic Goods Administration (TGA) depending on the compound. The Customs (Prohibited Imports) Regulations provide a framework for regulated chemical imports. Australian researchers are strongly advised to verify import requirements for specific compounds before ordering. LarnaLabs will provide all standard documentation but cannot guarantee customs clearance.
Research chemicals in Canada are regulated under the Food and Drugs Act, the Controlled Drugs and Substances Act, and Health Canada guidelines. Research institutions importing regulated compounds typically require licences or permits from Health Canada. Researchers should verify the status of specific compounds prior to importation. The Canada Border Services Agency may require additional documentation for clearance.
If you have questions about our compliance practices, documentation requirements for your jurisdiction, or the regulatory status of specific products, please contact us:
We will respond to compliance inquiries within 2 business days. For complex regulatory questions, we recommend engaging your institution’s legal or regulatory affairs department.
